Concepedia

Publication | Closed Access

Intraperitoneal radioimmunotherapy of ovarian cancer with lutetium-177-CC49.

106

Citations

15

References

1996

Year

Abstract

Intraperitoneal radioimmunotherapy with 177Lu-CC49 is well tolerated and appears to have antitumor activity against chemotherapy-resistant ovarian cancer in the peritoneal cavity.

References

YearCitations

Page 1